These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 11871864

  • 1. Chemotherapy in patients with metastatic or relapsed germ-cell tumours.
    Rick O, Siegert W, Beyer J.
    Cancer Treat Rev; 2001 Oct; 27(5):283-8. PubMed ID: 11871864
    [Abstract] [Full Text] [Related]

  • 2. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C, Harstrick A, Beyer J, Metzner B, Rüther U, Hartmann JT, Holstein K, Derigs HG, de Wit R, Casper J, Schöffski P, Kührer I, Illiger HJ, Kempf B, Reichle A, Föller A, Hossfeld DK, Fischer JT, Berdel WE, Gerhartz HH, Kirchner H, Pflüger KH, Ostermann H, Kanz L, Schmoll HJ.
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
    [Abstract] [Full Text] [Related]

  • 3. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].
    Fléchon A, Biron P, Philip I, Blay JY, Droz JP.
    Bull Cancer; 1999 Apr; 86(4):391-9. PubMed ID: 10341344
    [Abstract] [Full Text] [Related]

  • 4. Salvage chemotherapy after failure of first-line chemotherapy in patients with metastatic testicular cancer.
    Kollmannsberger C, Bokemeyer C.
    Curr Opin Support Palliat Care; 2008 Sep; 2(3):167-72. PubMed ID: 18685416
    [Abstract] [Full Text] [Related]

  • 5. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors.
    Kondagunta GV, Bacik J, Donadio A, Bajorin D, Marion S, Sheinfeld J, Bosl GJ, Motzer RJ.
    J Clin Oncol; 2005 Sep 20; 23(27):6549-55. PubMed ID: 16170162
    [Abstract] [Full Text] [Related]

  • 6. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ, Kollmannsberger C, Metzner B, Hartmann JT, Schleucher N, Schöffski P, Schleicher J, Rick O, Beyer J, Hossfeld D, Kanz L, Berdel WE, Andreesen R, Bokemeyer C, German Testicular Cancer Study Group.
    J Clin Oncol; 2003 Nov 15; 21(22):4083-91. PubMed ID: 14568987
    [Abstract] [Full Text] [Related]

  • 7. Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study.
    Mardiak J, Sálek T, Sycová-Milá Z, Obertová J, Hlavatá Z, Mego M, Recková M, Koza I.
    Neoplasma; 2005 Nov 15; 52(6):497-501. PubMed ID: 16284696
    [Abstract] [Full Text] [Related]

  • 8. Paclitaxel in salvage therapy for germ cell tumors.
    Motzer RJ.
    Semin Oncol; 1997 Oct 15; 24(5 Suppl 15):S15-83-S15-85. PubMed ID: 9346229
    [Abstract] [Full Text] [Related]

  • 9. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M, Miyake H, Hara I, Muramaki M, Takenaka A, Fujisawa M.
    Hinyokika Kiyo; 2007 Dec 15; 53(12):851-6. PubMed ID: 18203521
    [Abstract] [Full Text] [Related]

  • 10. Long-term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy.
    Beyer J, Kingreen D, Krause M, Schleicher J, Schwaner I, Schwella N, Huhn D, Siegert W.
    Cancer; 1997 Jan 01; 79(1):161-8. PubMed ID: 8988741
    [Abstract] [Full Text] [Related]

  • 11. The status of high-dose chemotherapy with hematopoietic stem cell transplantation in germ cell tumor patients.
    De Giorgi U, Rosti G, Papiani G, Marangolo M.
    Haematologica; 2002 Jan 01; 87(1):95-104. PubMed ID: 11801470
    [Abstract] [Full Text] [Related]

  • 12. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
    Sammler C, Beyer J, Bokemeyer C, Hartmann JT, Rick O.
    Eur J Cancer; 2008 Jan 01; 44(2):237-43. PubMed ID: 18055194
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy.
    Ronnen EA, Kondagunta GV, Bacik J, Marion S, Bajorin DF, Sheinfeld J, Bosl GJ, Motzer RJ.
    J Clin Oncol; 2005 Oct 01; 23(28):6999-7004. PubMed ID: 16192587
    [Abstract] [Full Text] [Related]

  • 15. [Two cases of relapse or refractory germ cell tumor who had been treated with combination chemotherapy of cisplatin and carboplatin].
    Kiyama Y, Suzuki G, Masauzi N, Ohizumi H, Kobayashi N, Ogasawara M, Naohara T, Saito M, Higa T, Kasai M.
    Gan To Kagaku Ryoho; 1996 Dec 01; 23(14):1989-92. PubMed ID: 8978809
    [Abstract] [Full Text] [Related]

  • 16. Salvage chemotherapy for recurrent germ cell cancer.
    Nichols CR, Roth BJ, Loehrer PJ, Williams SD, Einhorn LH.
    Semin Oncol; 1994 Oct 01; 21(5 Suppl 12):102-8. PubMed ID: 7992061
    [Abstract] [Full Text] [Related]

  • 17. [Germ cell tumor].
    Kasai M, Kiyama Y.
    Gan To Kagaku Ryoho; 1995 Oct 01; 22(12):1749-55. PubMed ID: 7574805
    [Abstract] [Full Text] [Related]

  • 18. [Current status and future perspectives in chemotherapy for testicular cancer].
    Kawai K.
    Gan To Kagaku Ryoho; 2003 Feb 01; 30(2):171-80. PubMed ID: 12610862
    [Abstract] [Full Text] [Related]

  • 19. Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors.
    Park S, Lee S, Lee J, Park SH, Park JO, Kang WK, Park YS, Lim HY.
    Onkologie; 2011 Feb 01; 34(8-9):416-20. PubMed ID: 21934340
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.